Roche Bumps Illumina Cash Offer Up To $6.5B
Roche Holding AG has boosted its offer to buy gene-sequencing company Illumina Inc. to $51 per share — more than $6.5 billion overall — in an appeal to get company leaders...To view the full article, register now.
Already a subscriber? Click here to view full article